Home
About
Overview
Sharing Data
ORCID
Help
History (90)
Inequalities in Household Catastrophic Health Expenditure and Impoverishment Associated With Noncommunicable Diseases in Chi Linh, Hai Duong, Vietnam.
Functional and diffusion-weighted magnetic resonance imaging for visualization of the postthalamic visual fiber tracts and the visual cortex.
Phosphatidate Phosphatase
Does retention matter? Treatment duration and improvement in drug use.
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
See All 90 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
Paul B, Rodriguez C, Usmani SZ. BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy. Drugs. 2022 Apr; 82(6):613-631.
View in:
PubMed
subject areas
B-Cell Maturation Antigen
Biological Therapy
Humans
Immunotherapy, Adoptive
Multiple Myeloma
Neoplasm Recurrence, Local
Standard of Care
authors with profiles
Saad Usmani MD